L

LegoChem Biosciences Inc
KOSDAQ:141080

Watchlist Manager
LegoChem Biosciences Inc
KOSDAQ:141080
Watchlist
Price: 103 300 KRW 6.17% Market Closed
Market Cap: 3.8T KRW
Have any thoughts about
LegoChem Biosciences Inc?
Write Note

LegoChem Biosciences Inc
Investor Relations

LegoChem Biosciences Inc., rooted in South Korea, is navigating the complex world of pharmaceutical innovation with a focus sharp enough to captivate both scientists and investors. Founded in 2006, the company has honed its expertise particularly in the field of antibody-drug conjugates (ADCs). This novel approach merges the targeting capabilities of antibodies with the cancer-killing prowess of chemotherapy drugs, aiming to deliver high precision in cancer treatment while minimizing side effects. LegoChem conducts meticulous research and development, advancing its proprietary ConjuAll™ technology platform, which enhances the stability and efficacy of ADCs. This dedication to scientific innovation underscores the company's strategy of robust collaboration and partnerships with global pharmaceutical giants, enabling it to leverage complementary expertise and expedite the commercialization of its cutting-edge therapies.

LegoChem Biosciences generates revenue primarily through a strategic business model that revolves around licensing agreements and research collaborations with major pharmaceutical players. The company enters into partnerships where it licenses out its advanced drug discovery platforms, receiving upfront payments, milestones based on developmental progress, and royalties upon successful commercialization of its licensed products. These collaborative strategies not only finance ongoing research but also diversify revenue streams and mitigate the inherent financial risks associated with drug development. By focusing on areas with high unmet medical needs, LegoChem not only positions itself advantageously in the competitive biotech landscape but also aligns with a mission to transform lives through innovation. With a clear-eyed vision and strategic partnerships, LegoChem Biosciences Inc. continues its quest to make significant strides in the realm of targeted cancer therapies.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Yong Zu Kim Ph.D.
CEO, President & Director
No Bio Available
Mr. Sejin Park
CFO, COO, Vice President & Director
No Bio Available
Mr. Yeong Soo Oh
Chief Technology Officer and Executive Vice President
No Bio Available
Mr. Jeiwook Chae
Chief Business Development Officer
No Bio Available
Dr. Young-Lag Cho Ph.D.
Chief Development Officer & Head Researcher & Development
No Bio Available
Dr. Chul-Woong Chung
Head of ADC Center
No Bio Available
Dr. Rodrigo Ruiz Soto M.D.
Chief Medical Officer
No Bio Available

Contacts

Address
DAEJEON
DAEJEON
10, Gukjegwahak 10-ro, Yuseong-gu
Contacts